← Career intelligence
Free · no sign-up · 3,138 priced deals

The deal tape

A precedent transactions set answers one question: what did somebody actually pay for a company like this one. Every row here is a US public target that filed a merger proxy or a going-private statement since 2020, with the offer per share, the premium to the unaffected price and the enterprise value multiples read from the filing itself rather than bought from a feed. Choose a sector, an industry code and a size band, and the quartiles above the list are the answer for that cut.

What it is not. Private-company deals, non-US targets and any transaction where no proxy was required leave nothing to read, so none of them are here. Neither are minority stakes or asset sales. Where a cross-check failed, the row still appears and says why, and it is held out of every median and quartile so one bad reading cannot move a number you would quote.

What this cut was bought at

Each measure counts the readings that survive its own cross-checks. Fewer than 4 is a coincidence, not a market.

MeasureDeals25thMedian75th
EV / LTM EBITDA4708.2x12.7x19.1x
EV / LTM revenue6970.9x1.9x3.6x
Premium to unaffected price64920%32%52%
Premium to 30-day VWAP12220%37%50%

Read the EBITDA multiple against the revenue multiple before you use either. Where they disagree sharply the target was priced on growth rather than earnings, and the EBITDA line is the one that will not survive a second question.

Deals by year of announcement
041812009: 5 deals, 1 clean on every measure200952010: 66 deals, 16 clean on every measure2010662011: 76 deals, 46 clean on every measure2011762012: 75 deals, 64 clean on every measure2012752013: 81 deals, 71 clean on every measure2013812014: 55 deals, 50 clean on every measure2014552015: 61 deals, 57 clean on every measure2015612016: 66 deals, 63 clean on every measure2016662017: 60 deals, 51 clean on every measure2017602018: 67 deals, 62 clean on every measure2018672019: 63 deals, 59 clean on every measure2019632020: 51 deals, 43 clean on every measure2020512021: 72 deals, 62 clean on every measure2021722022: 60 deals, 54 clean on every measure2022602023: 57 deals, 43 clean on every measure2023572024: 69 deals, 59 clean on every measure2024692025: 57 deals, 47 clean on every measure2025572026: 32 deals, 24 clean on every measure202632
Clean on every measure In doubt on one measure or both
Median EV / LTM EBITDA by sector
Healthcare: 18.8x median across 49 dealsHealthcare18.8xn=49Technology: 18.2x median across 96 dealsTechnology18.2xn=96Financials: 17.7x median across 11 dealsFinancials17.7xn=11Real Estate: 17.2x median across 20 dealsReal Estate17.2xn=20Business Services: 13.2x median across 27 dealsBusiness Services13.2xn=27Industrials: 12.9x median across 73 dealsIndustrials12.9xn=73Utilities: 10.8x median across 37 dealsUtilities10.8xn=37Materials: 9.7x median across 22 dealsMaterials9.7xn=22Other: 9.5x median across 19 dealsOther9.5xn=19Energy: 9.5x median across 22 dealsEnergy9.5xn=22Consumer & Retail: 9.5x median across 74 dealsConsumer & Retail9.5xn=74Media & Telecom: 9.4x median across 20 dealsMedia & Telecom9.4xn=20
Deals by sector
Technology: 226 dealsTechnology226Healthcare: 177 dealsHealthcare177Industrials: 136 dealsIndustrials136Consumer & Retail: 117 dealsConsumer & Retail117Financials: 106 dealsFinancials106Business Services: 66 dealsBusiness Services66Real Estate: 51 dealsReal Estate51Utilities: 43 dealsUtilities43Materials: 42 dealsMaterials42Energy: 40 dealsEnergy40Media & Telecom: 40 dealsMedia & Telecom40Other: 29 dealsOther29
Deals by buyer type
Financial sponsor: 123 dealsFinancial sponsor123Strategic: 1073 dealsStrategic1073Management / founder: 2 dealsManagement / founder2Controlling holder: 10 dealsControlling holder10Acquisition vehicle: 0 dealsAcquisition vehicle0Unclassified: 913 dealsUnclassified913
Deals by enterprise value
Under $250m: 361 dealsUnder $250m361$250m to $1bn: 262 deals$250m to $1bn262$1bn to $5bn: 304 deals$1bn to $5bn304$5bn to $20bn: 117 deals$5bn to $20bn117Over $20bn: 20 dealsOver $20bn20Not computed: 9 dealsNot computed9
Deals by industry code
Business Services & Software: 179 dealsBusiness Services & Sof…179Chemicals, Pharmaceuticals & Allied Products: 120 dealsChemicals, Pharmaceutic…120Electronics & Electrical Equipment: 99 dealsElectronics & Electrica…99Instruments, Medical Devices & Optical Goods: 70 dealsInstruments, Medical De…70Industrial Machinery & Computers: 43 dealsIndustrial Machinery & …43Electric, Gas & Sanitary Services: 43 dealsElectric, Gas & Sanitar…43Holding & Other Investment Offices: 38 dealsHolding & Other Investm…38Depository Institutions: 37 dealsDepository Institutions37Insurance Carriers: 35 dealsInsurance Carriers35Communications: 32 dealsCommunications32
TargetAcquirerIndustryEVEV / EBITDAEV / revenuePremiumFiling
Coeptis Therapeutics Inc.
2022-09-30 (filed) · Public merger · $10.00 a share
Bull Horn Holdings Corp.
Strategic
Healthcare$383mn.a.n.a.
n.a.
DEFM14A
All cash
O2micro International Ltd
2022-09-30 · Take-private · $0.10 a share
Board book on file →
Fnof Dynamic Holdings LTD
Strategic
Technology$93m5.7x0.9x
69%
SC 13E3
All cash
Turquoise Hill Resources Ltd.
2022-09-29 (filed) · Take-private · $43.00 a share
Held out of the multiples: no balance sheet at announcement: EV = equity value
Board book on file →
46117 Yukon Inc.
Strategic
Materials$8.7bnn.a.n.a.
67%
SC 13E3
All cash
Store Capital LLC
2022-09-15 · Public merger · $32.25 a share
Ivory REIT, LLC
Strategic
Real Estate$9.1bnn.a.10.6x
20%
DEFM14A
All cash
Channeladvisor Corp
2022-09-04 · Public merger · $23.10 a share
CommerceHub, Inc.
Strategic
Technology$579m26.5x3.4x
57%
DEFM14A
All cash
Signify Health, Inc.
2022-09-02 · Public merger · $30.50 a share
CVS Pharmacy, Inc.
Strategic
Healthcare$5.3bnn.a.6.3x
n.a.
DEFM14A
All cash
Aerie Pharmaceuticals Inc
2022-08-22 · Public merger · $15.25 a share
Alcon Research, LLC
Strategic
Healthcare$568mn.a.2.7x
39%
DEFM14A
All cash
Avalara, Inc.
2022-08-08 · Public merger · $93.50 a share
Lava Intermediate, Inc.
Strategic
Technology$6.8bnn.a.8.6x
27%
DEFM14A
All cash
Global Blood Therapeutics, Inc.
2022-08-07 · Public merger · $68.50 a share
Pfizer Inc.
Strategic
Healthcare$4.4bnn.a.18.5x
102%
110% to VWAP
DEFM14A
All cash
Cyberoptics Corp
2022-08-07 · Public merger · $54.00 a share
Nordson Corporation
Strategic
Industrials$380m18.7x3.7x
n.a.
DEFM14A
All cash
Irobot Corp
2022-08-04 · Public merger · $51.75 a share
Amazon.com, Inc.
Strategic
Technology$1.3bnn.a.n.a.
n.a.
25% to VWAP
DEFM14A
All cash
Irobot Corp
2022-08-04 · Public merger · $61.00 a share
Amazon.com, Inc.
Strategic
Technology$1.6bnn.a.n.a.
22%
48% to VWAP
DEFM14A
All cash
Ping Identity Holding Corp.
2022-08-02 · Public merger · $28.50 a share
Project Polaris Holdings, LP
Strategic
Technology$2.5bnn.a.8.2x
63%
DEFM14A
All cash
EVO Payments, Inc.
2022-08-01 · Public merger · $34.00 a share
Held out of the multiples: EV / LTM EBITDA 0.9x outside 1x to 75x
Global Payments Inc.
Strategic
Business Services$149m0.9x0.3x
n.a.
DEFM14A
All cash
Cowen Inc.
2022-08-01 · Public merger · $39.00 a share
The Toronto-Dominion Bank
Strategic
Financials$146mn.a.0.1x
49%
DEFM14A
All cash
Realnetworks Inc
2022-07-27 · Take-private · $0.73 a share
Board book on file →
GH Sliver, Inc.
Strategic
Technology$20mn.a.0.4x
55%
SC 13E3
All cash
Shell Midstream Partners, L.P.
2022-07-25 · Take-private · $15.85 a share
Board book on file →
Shell USA, Inc.
Strategic
Energy$5.9bn22.1x11.9x
n.a.
25% to VWAP
SC 13E3
All cash
1Life Healthcare Inc
2022-07-20 · Public merger · $18.00 a share
Amazon.com, Inc.
Strategic
Healthcare$3.1bnn.a.3.5x
83%
DEFM14A
All cash
GLORY STAR NEW MEDIA GROUP HOLDINGS Ltd
2022-07-11 · Take-private · $1.55 a share
Board book on file →
Cheers Inc.
Strategic
Technology$61mn.a.0.4x
76%
46% to VWAP
SC 13E3
All cash
Resolute Forest Products Inc.
2022-07-05 · Public merger · $20.50 a share
Domtar Corporation
Strategic
Materials$1.5bnn.a.0.4x
70%
DEFM14A
All cash
Usa Truck Inc
2022-06-23 · Public merger · $31.72 a share
Schenker, Inc.
Strategic
Industrials$360m4.3x0.5x
n.a.
DEFM14A
All cash
Ocean Bio Chem Inc
2022-06-21 · Public merger · $13.08 a share
OneWater Marine Inc.
Strategic
Materials$122m10.6x1.9x
121%
DEFM14C
All cash
LAIX Inc.
2022-06-16 · Take-private · $1.90 a share
Board book on file →
Best Venture Technology LTD
Strategic
Consumer & Retail$84m9.6x0.8x
57%
SC 13E3
All cash
Steel Connect, Inc.
2022-06-12 · Take-private · $1.35 a share
Held out of the multiples: EV / LTM EBITDA 1007.8x outside 1x to 75x
Board book on file →
Handy & Harman LTD.
Strategic
Business Services$403m1007.8x1.4x
12%
SC 13E3
All cash
Hoegh LNG Partners LP
2022-05-25 · Take-private · $9.25 a share
Board book on file →
Hoegh LNG GP LLC
Strategic
Industrialsn.a.n.a.n.a.
8%
39% to VWAP
SC 13E3
All cash

How to use a set like this

Cut to the narrowest set that still holds eight or ten deals, then quote the range rather than the median. An interviewer who asks where software takes out will accept a spread and press on a single number, because the single number implies a precision the set does not have. Say which deals sit at each end and why: the top of a range is usually a contested auction or a strategic buyer with synergies, the bottom a controlling holder buying in the minority.

Premiums move with the reference price, not only with the deal. A bidder quotes the period that flatters the offer, so read the premium to the unaffected close beside the premium to the thirty-day average and notice when they diverge.

What each column means

Enterprise value.
Offer per share times shares outstanding, plus net debt at the last balance sheet before the merger agreement. It is blank where either piece was missing, and those rows are in the “not computed” band rather than in a size they never earned.
Premium.
The offer against the unaffected price, which is the last close before the deal became known. Where the filing states a premium to the thirty-day volume-weighted average, that is shown next to it.
Deal type.
A take-private is bought by an affiliate, which is what triggers the Schedule 13E-3 and the fuller disclosure that comes with it. A public merger is an arm’s-length buyer, disclosed through the merger proxy.
In doubt.
A cross-check the reading could not satisfy: an equity value far from the fee-table figure, a multiple outside any sane band, or consideration that is partly stock so the per-share cash figure is not the price. The row stays visible, and it is set aside only for the measures the doubt reaches. A cash-and-stock deal cannot price a multiple and still states a premium the filing itself computed, so it counts in one and not the other.

Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More